|Mr. Alvaro Francisco Torres||Founder, CEO & Interim Chairman||N/A||N/A||1979|
|Mr. Chris Naprawa||Pres||N/A||N/A||1970|
|Mr. Darren Collins||Advisor||N/A||N/A||1983|
|Mr. Andres Galofre||Co-founder & VP of Bus. Devel.s||N/A||N/A||1982|
|Ms. Wendy Kaufman CPA||Chief Financial Officer||N/A||N/A||N/A|
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America. It operates through four business units: Pharma Medical, Khiron Clinics, Wellness, and Dixie JV. The company focuses on the cultivation, production, distribution, and export of THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. It also develops CBD-based cosmeceutical products for women and men's categories; and operates the company owned medical clinics. In addition, the company develops cannabis products in the food and beverage, supplements, and pets categories. The company was founded in 2017 and is headquartered in Vancouver, Canada.
Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.